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Recent genome-wide association studies demonstrated association of single nucleotide polymorphisms (SNPs) in the TNFAIP3
regionat6q23withsystemiclupuserythematosus(SLE)inEuropean-Americanpopulations.Inthisstudy,weinvestigatedwhether
SNPsintheTNFAIP3regionareassociatedwithSLEalsoinaJapanesepopulation.Acase-controlassociationstudywasperformed
ontheSNPsrs13192841,rs2230926,andrs6922466in318JapaneseSLEpatientsand444healthycontrols.Associationofrs2230926
Gallele withSLEwas replicated inJapanese (allelic association P = .033, oddsratio[OR]1.47,recessive model P = .023,OR 8.52).
The association was preferentially observed in the SLE patients with nephritis. When the TNFAIP3 mRNA levels of the HapMap
samples were examined using GENEVAR database, the presence of TNFAIP3 rs2230926 G allele was associated with lower mRNA
expression of TNFAIP3 (P = .013). These results indicated that TNFAIP3 is a susceptibility gene to SLE both in the Caucasian and
Asian populations.
1.Introduction
Nuclear factor-κB(NF-κB)isatranscriptionfactorthatregu-
latesexpressionofvariousgenesincludingpro-inﬂammatory
cytokines. TNFAIP3 (tumor necrosis factor alpha-induced
protein 3) gene codes for A20, a ubiquitin-modifying
protein required to inhibit NF-κB activation by several
signalingpathwaysincludingTNFandToll-likereceptors[1].
TNFAIP3-deﬁcientmiceexhibitedmultipleorganinﬂamma-
tion and damage involving kidneys and joints [2]. NF-κB
inducesexpressionofA20;thus,A20playsaroleinanegative
feedback mechanism in NF-κBp a t h w a y .
The lupus phenotypes in Fcγ receptor IIb-deﬁcient
mice were reduced by treatment with NF-κB inhibitors [3],
suggesting a role of NF-κB activation in the pathogenesis of
systemiclupus erythematosus(SLE).A recent study reported
that A20 negatively regulates immunostimulatory eﬀects of
dendritic cells and attenuates antigen presentation [4]. Thus,
reduced function of A20 may induce excessive activation
of dendritic cells and lead to the loss of tolerance to self-
antigens.
Since a genome-wide association study (GWAS) con-
ducted by the Wellcome Trust Case Control Consortium
reported association of TNFAIP3 region single nucleotide
polymorphisms (SNPs) with rheumatoid arthritis (RA) and
Crohn’s disease in 2007 [5], association of SNPs in the region
surrounding TNFAIP3 at 6q23 has been reported in several
autoimmune diseases. Association of the TNFAIP3 region
has subsequently been replicated in RA [6, 7]a n dw a sa l s o
reported in SLE by two groups using GWAS [8, 9]. These
observations implicated that TNFAIP3 may be a common
susceptibility gene to multiple autoimmune diseases.
Speciﬁcally, Musone et al. reported independent asso-
ciation of three SNPs in the TNFAIP3 region, rs13192841,2 Journal of Biomedicine and Biotechnology
rs2230926, and rs6922466, with SLE in a European-
American population [8]. The SNP rs2230926 is located in
the coding region of TNFAIP3 and introduces amino acid
substitution of Phe to Cys at position 127 in the ovarian
tumor domain, which was suggested to participate in the
inhibitory function of A20 through deubiquitination of
adaptor proteins [1]. Cys127 allele product was modestly less
eﬀective in inhibiting NF-κB activation by TNF than Phe127
[8]. Recently, an extensive meta-analysis and imputation
study by Bates et al. [10] demonstrated that the strongest
associationwasdetectedatanintron2SNPrs5029939,which
was originally detected by Graham et al. [9]a n dw a si n
tight linkage disequilibrium (LD) with rs2230926. They also
showed that the carrier of the risk allele was at higher risk
of developing nephritis and hematological manifestations
[10]. SNPs rs13192841 and rs6922466 were mapped within
250kb upstream and downstream of the TNFAIP3 region,
respectively.
Recently, we demonstrated that IRF5 [11], STAT4 [12],
and BLK [13] are associated with SLE not only in the
Caucasians, but also in the Japanese. In this study, we carried
out a case-control association study of the SNPs in the
TNFAIP3 region to examine whether TNFAIP3 is involved
in genetic predisposition to SLE also in Japanese.
2. Patientsand Methods
2.1. Patients and Controls. A case-control association study
was conducted in 318 Japanese patients with SLE (19 males
and 299 females, mean ± SD age 41.4 ± 13.5 years) and 444
healthy controls (219 males and 225 females, mean ± SD age
34.0 ± 9.9 years), recruited at the University of Tsukuba,
JuntendoUniversity,andtheUniversityofTokyo.Allpatients
and healthy individuals were native Japanese living in the
central part of the Japan. All patients met the criteria for SLE
proposed by the American College of Rheumatology [14].
In addition to the originally recruited controls, genotype
data of 934 Japanese healthy controls were retrieved from
the “JSNP550typed” dataset in the JSNP DATABASE (http://
snp.ims.u-tokyo.ac.jp/jsnp gtype access.html) and analyzed
[15].
This study was reviewed and approved by the research
ethics committees of University of Tsukuba, Juntendo Uni-
versity, and the University of Tokyo. Informed consent was
provided by all donors.
2.2. DNA Samples. Genomic DNA was extracted from
peripheral blood leucocytes using QIAamp blood kit (QIA-
GEN, Hilden, Germany) and ampliﬁed using the GenomiPhi
DNA Ampliﬁcation Kit (Amersham Biosciences, Piscataway,
NJ, USA), following the manufacturer’s instructions. Whole
genome ampliﬁcation products were used for genotyping.
2.3. Genotyping. Genotyping of SNPs was carried out using
the TaqMan genotyping assay (Applied Biosystems, Foster
City, CA), according to the manufacturer’s instructions. The
TaqMan probes used in this study were as follows: assay
ID: C 1575524 10 (rs13192841), C 7701116 10 (rs2230926),
and C 29431844 10 (rs6922466). Ampliﬁcation was per-
formed in a 10μl reaction volume containing 5μlo fT a q M a n
Genotyping Master Mix and 0.125μl of TaqMan genotyping
assay mix using 7300 Real-Time PCR System (Applied
Biosystems). Thermal cycling conditions consisted of initial
denaturation at 95
◦C for 10 minutes, followed by 40 cycles of
95
◦C for 15 seconds and 60
◦Cf o r1m i n u t e .
Genotyping of 934 controls in the “JSNP550typed”
dataset was performed using the Illumina HumanHap550
BeadChip(Illumina,Inc.,SanDiego,CA),asindicatedinthe
JSNP DATABASE.
2.4. Association of TNFAIP3 SNP with TNFAIP3 mRNA
Expression. Association of TNFAIP3 rs2230926 genotype
with TNFAIP3 mRNA expression was examined using the
mRNA data from lymphoblastoid cell lines derived from
44 JPT (the Japanese in Tokyo, Japan) and 45 CHB (the
Han Chinese in Beijing, China) HapMap individuals avail-
able from the database of the Gene Expression Variation
( G E N E V A R )p r o j e c ta tt h eW e l l c o m eT r u s tS a n g e rI n s t i t u t e
(http://www.sanger.ac.uk/humgen/genevar/), as previously
described [11]. Genotypes of rs2230926 in HapMap samples
were available from HapMap database (http://www.hapmap
.org/index.html.en). Because there was no subject with G/G
g e n o typ e ,m R N Al e v e l so fTNFAIP3 were compared between
rs2230926 G/T (n = 24) and T/T (n = 65) subjects.
2.5. Statistical Analysis. Association analyses were conducted
by chi-square testusing 2 × 2 contingency tables. When 1 or
more of the variables in the contingency tables was 5 or less,
Fisher’s exact test was employed. Because this study intended
to examine whether the association of TNFAIP3 is replicated
in Japanese, correction for multiple testing was not applied
and the uncorrected P values are shown.
Based on the allele frequencies in Japanese, the sample
size of this study (318 patients and 444 controls) had the
power of 80% to detect association when the genotype
relative risk is 1.55 (rs13192841), 1.65 (rs2230926), and 1.45
(rs6922466), respectively [16].
To examine LD between the SNPs in the TNFAIP3
region, LD parameters (D  and r2) were calculated using
Haploview version 4.0 software (Broad Institute of MIT and
Harvard, Cambridge, MA), based on data from the 444
healthy Japanese controls.
Diﬀerence in the mRNA expression between the
rs2230926 G/T and T/T subjects in the HapMap subjects was
analyzed by unpaired Student’s t-test.
3. Results and Discussion
To examine whether TNFAIP3 is associated with SLE in a
Japanese population, an association study of rs13192841,
rs2230926, and rs6922466 was conducted in 318 Japanese
patients with SLE and 444 healthy controls. As observed in
Caucasians [8], LD was modest among the examined three
SNPs in 444 healthy Japanese controls (r2: 0.00–0.11, D :
0.04–0.40). On the other hand, the intron 2 SNP rs5029939,
which showed the strongest association in the study ofJournal of Biomedicine and Biotechnology 3
Table 1: Association of the TNFAIP3 region SNPs with SLE in a Japanese population.
Allele n (%)
versus controls (n = 444) versus JSNP controls (n = 934)
Genotype n (%) Allelic association Recessive model
# Allelic association Recessive model
#
P OR
(95%CI)
P OR
(95%CI)
P OR
(95%CI)
P OR
(95%CI)
rs13192841 A/A G/A G/G A
SLE 5(1.6) 64(20.1) 249(78.3) 74(11.6) .43
1.14
(0.82–
1.58)
.29
2.35
(0.58–
9.51)
.45
1.12
(0.84–
1.48)
.36
1.64
(0.55–
4.88)
controls 3(0.7) 86(19.4) 355(80.0) 92(10.4) reference reference
JSNP controls
∗ 9(1.0) 179(19.2) 745(79.8) 197(10.6) reference reference
rs2230926 G/G T/G T/T G
SLE 6(1.9) 56(17.6) 256(80.5) 68(10.7) .033
1.47
(1.03–
2.09)
.023
8.52
(1.45–
50.1)
6.2 ×10
−4
1.17
(1.26–
2.33)
.049
2.97
(1.00–
8.82)
controls 1(0.2) 65(14.6) 378(85.1) 67(7.5) reference reference
JSNP controls
∗ 6(0.6) 110(11.8) 818(87.6) 122(6.5) reference reference
rs6922466 G/G A/G A/A G
SLE 12(3.8) 86(27.0) 220(69.2) 110(17.3) .80
0.97
(0.74–
1.26)
.97
0.99
(0.46–
2.09)
.20
0.86
(0.68–
1.09)
.40
0.76
(0.40–
1.45)
controls 17(3.8) 124(27.9) 303(68.2) 158(17.8) reference reference
JSNP controls
∗ 46(4.9) 274(29.3) 614(65.7) 366(19.6) reference reference
OR: odds ratio, 95%CI: conﬁdence interval.
∗Genotype data of healthy Japanese individuals obtained from JSNP DATABASE.
#Recessive model for the minor allele.
Bates et al. [10], was in strong LD with rs2230926 also in
Japanese (HapMap JPT: r2 = 0.86, D  = 1.0). None of the
control genotypes were signiﬁcantly deviated from Hardy-
Weinberg equilibrium.
The association of rs2230926 with SLE was replicated in
the Japanese, while evidence for association of rs13192841
and rs6922466 was not detected (Table 1). To conﬁrm our
ﬁndings, the patients’ genotypes were also compared with
the genotypes of 934 Japanese controls available from JSNP
DATABASE. As shown in Table 1, rs2230926 G allele fre-
quency was signiﬁcantly increased in SLE patients compared
with JSNP controls. On the other hand, association of
rs13192841 and rs6922466 was not detected, even when the
JSNP controls were used for comparison.
Because the minor allele frequency of rs6920220, pre-
viously shown to be associated both with RA and SLE in
European-American populations [6, 7, 9], was only 0.006 in
the HapMap JPT samples, association was not examined for
this SNP.
We next tested whether rs2230926 in TNFAIP3 was
associated with the development of nephritis. Frequency
of rs2230926 G allele was signiﬁcantly increased in SLE
with nephritis (12.2%) as compared with healthy controls
(7.5%, P = .010, OR 1.70, 95%CI 1.13–2.56), while
signiﬁcant diﬀerence was not observed between SLE with-
out nephritis (8.6%) and healthy controls (Table 2). This
ﬁnding is in agreement with Bates et al., who demonstrated
preferential association of TNFAIP3 with SLE patients with
nephritis in Caucasians [10]. Bates et al. also reported
association of TNFAIP3 with hematological manifestations
[10]. We did not carry out this analysis, however, because
more than 90% of our patients fulﬁlled ACR classiﬁcation
criteria for hematologic disorder, especially lymphopenia
(1500/μl).
A previous study suggested that the product of the
risk allele, rs2230926 G (Cys127), may be modestly less
eﬃcient in inhibiting TNF-induced NF-κBa c t i v i t y[ 8].
To gain more insight into the functional signiﬁcance of
rs2230926, association of TNFAIP3 mRNA levels with
genotype was evaluated using the HapMap JPT and CHB
subjects. Data on the mRNA levels in B cell lines from
HapMap samples were obtained from GENEVAR database
(http://www.sanger.ac.uk/humgen/genevar/). As shown in
Figure 1, the levels of TNFAIP3 mRNA were decreased
in carriers of the rs2230926 G allele (G/T subjects) as
compared with noncarriers (T/T) (P = .013). This ﬁnding
is in agreement with a previous study which demonstrated
that TNFAIP3 intronic SNP rs5029930, which is strong LD
with rs2230926 G, was associated with lower expression
of TNFAIP3 mRNA expression in peripheral mononuclear
cells [17]. Thus, our ﬁndings suggested that the molecular
mechanisms of association of TNFAIP3 haplotype contain-
ing rs2230926 G and rs5029939 G may involve both the
functional change caused by the amino acid substitution at
the protein level and the reduced expression level of A20
protein.4 Journal of Biomedicine and Biotechnology
Table 2: Association of TNFAIP3 rs2230926 with presence or absence of nephritis.
rs2230926 Genotype Allele Allelic association Recessive model
∗ Dominant model
∗
G/G T/G T/T G P OR
(95%CI)
P OR
(95%CI)
P OR
(95%CI)
SLE
with nephritis (n=168) 4(2.4) 33(19.6) 131(78.0) 41(12.2) .010 1.70
(1.13–2.56)
.022 10.8
(1.85–63.2)
.035 1.62
(1.03–2.53)
without nephritis (n=145) 2(1.4) 21(14.5) 122(84.1) 25(8.6) .55 1.16
(0.72–1.87)
.15 6.20
(0.75–51.1)
.77 1.08
(0.64–1.81)
Controls (n=444) 1(0.2) 65(14.6) 378(85.1) 67(7.5) reference reference reference
OR: odds ratio, 95%CI: conﬁdence interval. Parentheses in the genotype and allele frequency columns indicate percentages.
∗Recessive and dominant models for the G allele.
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Figure 1: Association of TNFAIP3 rs2230926 with mRNA levels
of TNFAIP3. Because there was no subject with G/G genotype,
TNFAIP3mRNAlevelswerecomparedbetweenrs2230926G/T(n=
24, mean ± SD: 12.0 ± 0.43) and T/T (n = 65, mean ± SD: 12.2 ±
0.33) subjects by unpaired Student’s t-test. The mRNA levels were
obtainedfromthemRNAexpressionproﬁlingdataintheBcelllines
from the HapMap JPT and CHB subjects (GENEVAR database).
A GWAS of SLE in a Chinese Han population was
very recently reported for the ﬁrst time in non-Caucasian
populations [18]. In the study, association of TNFAIP3
rs2230926, but not rs13192841 and rs6922466, with SLE
was demonstrated, which was consistent with our results in
Japanese. Thus, taken together with previous observations,
our study established TNFAIP3 as a susceptibility gene
to SLE common to Caucasian and Asian populations. Of
particular interest, both the GWAS in Chinese [18]a n da
large-scale study in Caucasians [19] identiﬁed association of
TNFAIP3 interacting protein 1 (TNIP1), which binds to A20
and is thought to inhibit NF-κB signaling. These ﬁndings
underscore the crucial role of NF-κB regulation pathway in
the genetic background of SLE in multiple populations.
4. Conclusions
The association of rs2230926 in the coding region of
TNFAIP3 with SLE was replicated in a Japanese population.
Our ﬁnding demonstrated that TNFAIP3 is a susceptibility
gene to SLE both in the Asian and Caucasian populations.
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